(NasdaqGM:IVVD), WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA(R) (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network(R) (NCCN(R)) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas. NCCN joins the Infectious Disease Society of America (IDSA) that updated its COVID-19 guidelines in […]

(NasdaqGM:VEON), Islamabad and Dubai, May 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has now secured all regulatory approvals for its strategic partnership with Engro Corporation Limited (“Engro Corp”) for the pooling and management of telecommunications infrastructure assets in Pakistan. The partnership, initially announced on December

Invivyd Announces Inclusion of PEMGARDA(R) (pemivibart) in National Comprehensive Cancer Network(R) (NCCN(R)) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas GlobeNewswire May 23, 2025 WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA(R) (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network(R) (NCCN(R))

Submission follows receipt of final federal permit. Application submitted for up to $2 billion, an increase from the $1.8billion Letter of Interest, reflecting a higher estimatednumber ofjob-years. If approved, EXIM debt financing could fund a majority of the Project's development costs to become the only domestically minedsource ofantimony. Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA)

— Initial safety & efficacy in patients with Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC) with Driver Genomic Alterations (GA) outside of Classic EGFR Mutations will be presented from clinical studies evaluating iza-bren, an EGFRxHER3 bispecific topoisomerase inhibitor- based antibody-drug conjugate (ADC) SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced

VEON and Engro Corporation Advance to Closing Pioneering Infrastructure Partnership in Pakistan Following Regulatory Approvals GlobeNewswire May 23, 2025 Islamabad and Dubai, May 23, 2025: VEON Ltd. (Nasdaq: VEON), a global digital operator (“VEON” or “the Company”), announces that it has now secured all regulatory approvals for its strategic partnership with Engro Corporation Limited (“Engro

Shares Preliminary Fiscal Year 2025 Results and Updated Fiscal 2026 OutlookFourth Quarter Fiscal 2025 Conference Call Set for Monday, June 16, 2025 In advance of its participation in the 22nd AnnualCraig-Hallum Institutional Investor Conference (May 28) and William Blair's 45th Annual Growth Stock Conference (June 4), Powerfleet, Inc. (Nasdaq: AIOT) today provided a business update,

Old Republic International Corporation (NYSE: ORI) – today announced its Board of Directors has declared a regular quarterly cash dividend of 29 cents per share. This dividend is payable on June 16, 2025 to shareholders of record on June 6, 2025. Subject to Board approval of each quarter's new rate, the full year's cash dividend

Bank of America Corporation announced today that it will redeem on June 12, 2025 allCHF 375,000,000 principal amount outstanding of its 0.2525% Senior Notes, due June 12, 2026 (ISIN: CH0474977722; Common Code: 200733517) (the “Notes”). https://mma.prnewswire.com/media/1612970/Bank_of_America_Corporation_Logo.jpg The Notes were issued under the Bank of America Corporation U.S. $65,000,000,000 Euro Medium-Term Note Program. The redemption price

Pelareorep initiates a pro-inflammatory tumor microenvironment (TME) and induces innate and adaptive immune responses New analyses confirm that pelareorep primes the TME to allow circulating tumor-infiltrating lymphocytes (TILs) in the blood to attack tumors Pre-existing TIL clones in plasma may correlate positively with tumor shrinkage in pancreatic cancer Oncolytics Biotech®Inc. (NASDAQ: ONCY) (TSX: ONC), a